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Objectives: Recent reports indicate the emergence of a new carbapenemase-producing Klebsiella pneumoniae
clone, ST307. We sought to better understand the global epidemiology and evolution of this clone and evaluate
its association with antimicrobial resistance (AMR) genes.
Methods: We collated information from the literature and public databases and performed a comparative ana-
lysis of 95 ST307 genomes (including 37 that were newly sequenced).
Results: We show that ST307 emerged in the mid-1990s (nearly 20 years prior to its first report), is already glo-
bally distributed and is intimately associated with a conserved plasmid harbouring the blaCTX-M-15 ESBL gene and
several other AMR determinants.
Conclusions: Our findings support the need for enhanced surveillance of this widespread ESBL clone in which
carbapenem resistance has occasionally emerged.
Introduction
Several reports have indicated the recent emergence of a new
MDR Klebsiella pneumoniae (Kp) clone, ST307. We have recently
generated data suggesting that ST307 is becoming an important
cause of ESBL-producing Kp infections in Norway (M. A. K. Hetland,
A. Fostervold, I. H. Lo¨hr on behalf of The Norwegian Study
Group on Klebsiella pneumoniae, unpublished data), and others
have reported it as an emerging cause of KPC-producing Kp infec-
tions.1–3
Here we summarize what is known in the literature and in-
vestigate 95 geographically diverse ST307 whole-genome
sequences from 11 countries to better understand the emer-
gence and global molecular epidemiology of this clone and
identify the antimicrobial resistance (AMR) genes with which it
is associated.
Materials and methods
Ethics
The proposed collection of novel clinical Kp isolates from Norway was
reviewed and approved by the Regional Committees for Medical and Health
Research Ethics West (Norway, application ID: 2017/1185).
Literature search
We searched PubMed for abstracts containing the words ‘ST307’ with/without
‘Klebsiella pneumoniae’ as of April 2018. ST307-isolate genomes were identi-
fied from our collections and public databases using Kleborate.4 In total, 549
published and 37 newly sequenced genomes were identified, representing 11
countries on five continents. However, we were unable to find corresponding
literature reports for 45 of the 58 genome assemblies identified among those
deposited in GenBank (as of December 2017) and hence these genomes were
excluded from comparative analyses.
VC The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
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Sequencing
Novel genomes were sequenced on the Illumina MiSeq platform generat-
ing 150 or 250 bp paired end (PE) reads as described previously.5 The oldest
isolate (Kp616 from Iran, 2009) was also subjected to long-read Oxford
Nanopore sequencing and hybrid genome assembly using Unicycler
v0.4.4.6,7 The completed Kp616 genome comprised a 5246307 bp chromo-
some plus two plasmids (pKp616_1, 58 kbp; pKp616_2, 55 kbp; GenBank
accession number GCA_003076555.1).
A core chromosomal single-nucleotide variant (SNV) alignment was
generated using RedDog (reference: Kp616 chromosome) as described pre-
viously.5 Recombination was removed using Gubbins.8 A preliminary tree
made using FastTree9 indicated that the majority of strains from Texas
(n"451/468, 96.4%) formed a distinct monophyletic clade; hence, we ran-
domly selected one isolate per year to represent this clade in comparative
analyses. The final recombination-free alignment of 1465 SNVs in 95
genomes was subjected to Bayesian phylogenetic analysis using BEAST 2
v2.4.710 as described previously.5 A GTR, relaxed clock, constant population
size model was determined to be the best fit and we confirmed a strong
temporal signal by date randomization and linear regression (Figure S1,
available as Supplementary data at JAC Online).
De novo genome assemblies were generated with Unicycler v0.4.4.6
AMR genes and virulence loci were detected using Kleborate.4,11,12 Capsule
synthesis (K) and lipopolysaccharide (O) loci were typed using Kaptive.13
Sample information accession numbers, citations and genotyping
results for the 95 genomes included in the final analyses are listed in Table
S1. Notably, this collection represents the most diverse sample of ST307 Kp
genomes to date, including isolates (i) from diverse sources, e.g.
human infections [urine (n"34), blood (n"31), respiratory (n"10) and
unknown/other (n"17)], two human rectal carriage isolates and one iso-
late from canal water; and (ii) from diverse geographies, including 47
genomes (49.5%) from seven countries not represented in previous com-
parative analyses.1,2
Results and discussion
A total of 26 literature reports were identified by systematic search
and a further 6 papers were identified by association with pub-
lished genome sequences (Table S2). The oldest recorded ST307
isolate was collected in The Netherlands in 2008 (Kp MLST data-
base; https://bigsdb.pasteur.fr/klebsiella/klebsiella.html) but the
earliest clinical strain reported in the literature was collected in
Pakistan in 2009.14 This was followed by sporadic isolations across
Europe, Asia, Africa and the Americas, the majority (.98%) from a
variety of human clinical specimens plus a minority from other
sources, e.g. human rectal samples, companion animals and envir-
onmental/sewage water samples (summarized in Table S2 and
Figure 1). Several reports indicated local dissemination of ST307
harbouring KPC genes, blaKPC-2 (Columbia, USA, South Korea) and
blaKPC-3 (Italy)
3,15–18 while an analysis of .1700 ESBL-producing
Kp from a hospital network in Texas, USA found high prevalence of
blaCTX-M-15-positive ST307 strains, 1/3 of which also carried
blaKPC-2 genes and three carried blaKPC-3.
1 This was consistent
with other reports that blaCTX-M-15 is common in ST307
1–3,14,19
(also see Table S2). Aside from blaKPC genes, carbapenem resist-
ance conferred by NDM-1 or OXA-48 carbapenemases has been
reported,1–3,19,20 as has resistance to the novel b-lactam inhibitor
combination ceftazidime/avibactam21 and colistin.20,22
We performed the first molecular dating analysis for ST307
using the 95 genomes in our final subsampled collection. This indi-
cated that ST307 emerged in 1994 [95% highest posterior density
(HPD), 1974–2006], close to the emergence date estimated
previously for ST258,23 despite the fact that the latter was reported
in the literature and recognized as a disseminated clone more
than a decade earlier than ST307.24 The estimated mutation rate
for ST307 (1.18%10#6 substitutions/site/year, 95% HPD,
8.01%10#7–1.58%10#6; Figure S1) was remarkably similar to
that estimated previously for ST258 (1.03%10#6 substitutions/
site/year, 95% HPD 8.09%10#7–1.24%10#6)23 but faster than that
of hypervirulent Kp ST23 (3.40%10#7 substitutions/site/year, 95%
HPD 2.43%10#7–4.38%10#7),5 which represent the only Kp clones
for which comparable analyses have been published to date.
The phylogeny revealed two deep-branching lineages, one of
which has become globally distributed, comprising genomes from
the Americas, Asia, Australia, the Middle East and Europe (includ-
ing the 12 genomes reported by Villa et al.2; see Figure 2 and also
available for interactive viewing at https://microreact.org/project/
ryiY_FlfQ). Within this lineage there was evidence of transfer of
ST307 between countries, and for all countries with three or more
genomes there were multiple clusters within the global lineage.
The countries with the highest representation were distributed
most broadly (Norway, n"30; USA, n"22; UK, n"22), suggesting
that the same patterns would likely be detected for most countries
if sampling was increased (Figure 2). The second lineage included
only subsampled strains from Texas (2011–15, shaded grey in
Figure 2), indicating that the majority of the hundreds of infections
attributed to ST307 in the report by Long et al.1 resulted from pro-
longed local transmission of this clade, a finding that was not pre-
viously evident because the genomes were not compared with
those from other geographies. Texan isolates were also found in
the global lineage, suggesting that the USA may be a potential ori-
gin for ST307, as most of its genetic diversity was present in that
location.
We used Kleborate4 to detect Kp virulence determinants that
are positively associated with invasive infections.11,12,25 While
these determinants are most commonly detected among drug-
susceptible ‘hypervirulent’ Kp, they are occasionally found among
MDR strains,11,12 posing a risk of severe, difficult-to-treat infections.
We detected no evidence of the Kp virulence plasmid (encoding
the salmochelin and aerobactin siderophores plus RmpA/RmpA2),26
but a minority of genomes (n"12, 12.6%) harboured the yersinia-
bactin siderophore locus located within three distinct chromoso-
mally integrated ICEKp variants (ICEKp3, ICEKp4 and ICEKp11).
Hence our data indicate a lower prevalence of ICEKp than that previ-
ously reported for ST307 (66%, 8 of 12 genomes investigated2).
The distribution of ICEKp insertions on the ST307 core genome tree
indicated more than four independent acquisitions with limited ex-
pansion of recipient sub-lineages (Figure 2), consistent with the pat-
terns recently reported for ST258 and other common MDR Kp
clones.11 Unlike these other clones,13,23 all ST307 shared the same
K and O loci (KL102, associated with wzi allele 173, and O2v2), both
of which have also been identified among various other Kp STs,
including those from other disseminated MDR clones, e.g. ST105,
ST152 and ST1583.12,13 An additional putative capsule synthesis
locus (Kp616 genes C2861_20465 to C2861_205202), which was
previously reported in ST3072 and is unlike any known K locus, was
also conserved (present at 95% nucleotide identity and 90%
coverage in 95/95 genomes) but is rare among the broader Kp
population (just 10 Kp nucleotide blast matches were identified in
the GenBank nucleotide database).
Wyres et al.
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In contrast to the virulence loci, acquired AMR genes were high-
ly prevalent; 93 (97.9%) isolates carried acquired resistance deter-
minants associated with three or more drug classes (Table S1). The
ParC 80I and GyrA 83I fluoroquinolone resistance-associated
mutations were conserved in all genomes. The blaCTX-M-15 ESBL
gene was found in 89 (93.7%) genomes, and 81 (85.3%) har-
boured it in combination with sul2, dfrA14 and strAB with/without
aac(3)-IIa, which were all linked to an MDR plasmid (see below).
blaKPCs and other AMR genes were occasionally identified (Figure 2
and Table S1). For the majority of genomes carrying blaCTX-M-15
(n"88/89), BLASTn confirmed that this gene was located
downstream of ISEcp1, which forms a transposon to mobilize
blaCTX-M-15 and promotes its expression.
27 Four complete ST307
IncFIIK/IncFIBK blaCTX-M-15 plasmids have been published,
2 and
share an insertion of the ISEcp1/blaCTX-M-15 transposon within Tn3.
Read-mapping to the largest of these plasmids, pKPN3-307_typeA
(accession KY271404) and assembly graph inspections of
our blaCTX-M-15-positive genomes showed that all carried the
same ISEcp1/blaCTX-M-15 transposon. In 82/89 cases, the same
pKPN3-307_typeA IncFIIK/IncFIBK plasmid backbone was present
and ISEcp1/blaCTX-M-15 was located in the same site within Tn3,
consistent with conservation of the same IncFIIK/IncFIBK ESBL
plasmid (including various deletion variants; Figure S2). The excep-
tions were as follows: (i) an Australian isolate (13GNB-468) had the
ISEcp1/blaCTX-M-15 transposon inserted in the chromosomal gene
feoB; (ii) Kp616 carried no pKPN3-307_typeA-like plasmid but
harboured blaCTX-M-15 on an IncN plasmid; and (iii) the five repre-
sentatives of the Texas-specific lineage carried two chromosomal
insertions of the ISEcp1/blaCTX-M-15 transposon (within Kp616 loci
C2861_02545 and C2861_22795, not detailed in the previous
study1). This, coupled with the additional GyrA 87N fluoroquino-
lone resistance mutation in the Texan lineage, may have contrib-
uted to its prolonged transmission in the hospital setting by
facilitating enhanced resistance to antimicrobials without any bur-
den of plasmid maintenance. Regardless of these exceptions, the
level of plasmid conservation in ST307 is remarkable, mirroring
the association of ST258 with the blaKPC pKpQIL plasmid
23 and
suggesting that the plasmid confers limited fitness cost to the host
(although plasmid-positive, blaCTX-M-15-negative genomes were
observed; Table S1).
Complementing the increasing reports in the literature, our
analyses reveal that ST307 is a highly successful MDR clone that
shares many traits with ST258 (i.e. date of emergence, evolution-
ary rate, high prevalence of AMR genes, low prevalence of ICEKps
but multiple independent acquisitions, and high conservation of a
single plasmid), but is closely associated with blaCTX-M-15 rather
than blaKPCs. With sufficient exposure ST307 can acquire and dis-
seminate carbapenemases,1–3 and likely other clinically important
AMR determinants. Our analyses show for the first time that ST307
is readily transferred between countries and has already become
globally disseminated but remained largely unnoticed for almost
20 years. These findings indicate an urgent need for enhanced
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Figure 1. Geographical distribution and increasing reports of ST307. (a) Countries of collection of ST307 isolates reported in the literature, the inter-
national K. pneumoniae MLST database and/or for which genome data are available (also see Table S2). Countries for which isolate genomes were
included in the current analysis are coloured as shown in Figure 2. All other countries where ST307 has been reported are coloured black. (b) Reports
of ST307 in the literature and among genome assemblies deposited in GenBank. Black bars show the cumulative number of PubMed abstracts as of
April 2018, identified using the search criteria ‘ST307’ with/without ‘Klebsiella pneumoniae’ (Table S2). The red line shows the cumulative number of
isolates for which genome assemblies are deposited in GenBank as of December 2017. Dates indicate year of isolate collection, not date of depos-
ition, hence recent values will likely increase as further genomes are deposited. The first ST307 isolate reported in the international MLST database
was collected in 2008.
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surveillance of MDR Kp to monitor ST307 alongside other well-
known clones and detect emerging MDR threats.
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Figure 2. Bayesian phylogeny of 95 ST307 isolates. (a) Dated phylogeny of ST307 isolates (n"95), with tips coloured by country of isolation (as
shown in the inset legend and Figure 1). Black dots on internal nodes indicate 95% posterior probability. Light grey shading shows subsampled
Texan-specific clade. (b) Presence of the yersiniabactin-carrying ICEKp elements (variants coloured as shown in the inset legend), antimicrobial resist-
ance genes (blocks coloured by drug class), and coverage of blaCTX-M-15 plasmid pKPN3-307_typeA. In the CTX-M-15 column: * indicates blaCTX-M-15 is
inserted in chromosome; ** blaCTX-M-15 inserted in IncN plasmid. Brown in the dfrA14 column indicates dfrA27 allele and black the dfrA12 allele. In the
KPC column, light pink indicates blaKPC-2 and dark pink indicates blaKPC-3. These data are available for interactive viewing at https://microreact.org/pro
ject/ryiY_FlfQ.
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